Blauvelt, A., C. Paul, P. van de Kerkhof, R. B. Warren, A. B. Gottlieb, R. G. Langley, F. Brock, C. Arendt, M. Boehnlein, M. Lebwohl, and K. Reich. “Long-Term Safety of Certolizumab Pegol in Plaque Psoriasis: Pooled Analysis over 3 Years from Three Phase 3, Randomized, Placebo-Controlled Studies”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 5, Sept. 2020, p. s46, doi:10.25251/skin.4.supp.46.